BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35255941)

  • 21. Juvenile Idiopathic Arthritis.
    Barut K; Adrovic A; Şahin S; Kasapçopur Ö
    Balkan Med J; 2017 Apr; 34(2):90-101. PubMed ID: 28418334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health-related quality of life and disability in adults with juvenile idiopathic arthritis: comparison with adult-onset rheumatic diseases.
    Oliveira Ramos F; Rodrigues A; Magalhaes Martins F; Melo AT; Aguiar F; Brites L; Azevedo S; Duarte AC; Furtado C; Mourão AF; Sequeira G; Cunha I; Figueira R; Melo Gomes JA; Santos MJ; Fonseca JE
    RMD Open; 2021 Nov; 7(3):. PubMed ID: 34819385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcriptomic signatures of classical monocytes reveal pro-inflammatory modules and heterogeneity in polyarticular juvenile idiopathic arthritis.
    Hounkpe BW; Sales LP; Ribeiro SCR; Perez MO; Caparbo VF; Domiciano DS; Figueiredo CP; Pereira RMR; Borba EF
    Front Immunol; 2024; 15():1400036. PubMed ID: 38835762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Infliximab therapy and outcomes in patients with polyarticular juvenile idiopathic arthritis: a single-center study in China.
    Liu DW; Chen JJ; Tang XM; Zhang Y; Zhou J
    World J Pediatr; 2020 Feb; 16(1):68-73. PubMed ID: 31612428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Health-related quality of life, physical function, fatigue, and disease activity in children with established polyarticular juvenile idiopathic arthritis.
    Ringold S; Wallace CA; Rivara FP
    J Rheumatol; 2009 Jun; 36(6):1330-6. PubMed ID: 19411394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physical disability, articular, and extra-articular damage in patients with juvenile idiopathic arthritis.
    Sarma PK; Misra R; Aggarwal A
    Clin Rheumatol; 2008 Oct; 27(10):1261-5. PubMed ID: 18500441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bayesian comparative effectiveness study of four consensus treatment plans for initial management of systemic juvenile idiopathic arthritis: FiRst-Line Options for Systemic juvenile idiopathic arthritis Treatment (FROST).
    Nigrovic PA; Beukelman T; Tomlinson G; Feldman BM; Schanberg LE; Kimura Y;
    Clin Trials; 2018 Jun; 15(3):268-277. PubMed ID: 29542334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of disease activity in a low-income juvenile idiopathic arthritis cohort.
    Rocha FAC; Landim JIVD; Aguiar MG; Accioly JPE; Lechiu CN; Costa LHA; Júnior CNR; da Rocha LN; Rocha HAL
    Rheumatol Int; 2019 Jan; 39(1):67-71. PubMed ID: 30101369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bone density, structure, and strength in juvenile idiopathic arthritis: importance of disease severity and muscle deficits.
    Burnham JM; Shults J; Dubner SE; Sembhi H; Zemel BS; Leonard MB
    Arthritis Rheum; 2008 Aug; 58(8):2518-27. PubMed ID: 18668565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Growth patterns in early juvenile idiopathic arthritis: Results from the Childhood Arthritis Prospective Study (CAPS).
    McErlane F; Carrasco R; Kearsley-Fleet L; Baildam EM; Wedderburn LR; Foster HE; Ioannou Y; Chieng SEA; Davidson JE; Thomson W; Hyrich KL
    Semin Arthritis Rheum; 2018 Aug; 48(1):53-60. PubMed ID: 29217290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Health-Related Quality of Life in an Inception Cohort of Children With Juvenile Idiopathic Arthritis: A Longitudinal Analysis.
    Oen K; Guzman J; Dufault B; Tucker LB; Shiff NJ; Duffy KW; Lee JJY; Feldman BM; Berard RA; Dancey P; Huber AM; Scuccimarri R; Cabral DA; Morishita KA; Ramsey SE; Rosenberg AM; Boire G; Benseler SM; Lang B; Houghton K; Miettunen PM; Chédeville G; Levy DM; Bruns A; Schmeling H; Haddad E; Yeung RSM; Duffy CM;
    Arthritis Care Res (Hoboken); 2018 Jan; 70(1):134-144. PubMed ID: 28320056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Longitudinal Health Status from Early Disease to Adulthood and Associated Prognostic Factors in Juvenile Idiopathic Arthritis.
    Tollisen A; Selvaag AM; Aasland A; Lerdal A; Flatø B
    J Rheumatol; 2019 Oct; 46(10):1335-1344. PubMed ID: 30877211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Juvenile Arthritis Disease Activity Score proves to be a useful tool in treat-to-target therapy in juvenile idiopathic arthritis.
    Swart JF; van Dijkhuizen EHP; Wulffraat NM; de Roock S
    Ann Rheum Dis; 2018 Mar; 77(3):336-342. PubMed ID: 29138257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disease activity and fatigue in juvenile idiopathic arthritis.
    Ringold S; Ward TM; Wallace CA
    Arthritis Care Res (Hoboken); 2013 Mar; 65(3):391-7. PubMed ID: 22807336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Juvenile idiopathic arthritis in the biologic era: predictors of the disease progression and need for early introduction of biologic treatment.
    Nalbanti P; Kanakoudi-Tsakalidou F; Trachana M; Pratsidou-Gertsi P; Farmaki E; Bamidis P; Papachristou F
    Rheumatol Int; 2018 Jul; 38(7):1241-1250. PubMed ID: 29845429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation of the French version of the Childhood Health Assessment Questionnaire (CHAQ) in juvenile idiopathic arthritis.
    Pouchot J; Larbre JP; Lemelle I; Sommelet D; Grouteau E; David L; Duquesne A; Deslandre CJ; Koné Paut I; Pillet P; Goumy L; Barbier C; Guyot MH; Mazingue F; Laloum SG; Fischbac M; Quartier P; Guyot C; Jean S; Legall E; Plouvier E; Bost M; de Lumley L; Brégeon C; Guillemin F; Coste J; Prieur AM;
    Joint Bone Spine; 2002 Oct; 69(5):468-81. PubMed ID: 12477231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strong relationships between disease activity, foot-related impairments, activity limitations and participation restrictions in children with juvenile idiopathic arthritis.
    Dekker M; Hoeksma AF; Dekker JH; van Rossum MA; Dolman KM; Beckerman H; Roorda LD
    Clin Exp Rheumatol; 2010; 28(6):905-11. PubMed ID: 21122275
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The correlation between the Childhood Health Assessment Questionnaire and disease activity in juvenile idiopathic arthritis.
    Sontichai W; Vilaiyuk S
    Musculoskeletal Care; 2018 Sep; 16(3):339-344. PubMed ID: 29573557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical profile and juvenile arthritis damage index in children with juvenile idiopathic arthritis: A study from a tertiary care center in south India.
    Menon NVB; Peethambaran G; Puthiyapurayil AT; Nambudakath C; Arakkal R
    Int J Rheum Dis; 2018 Apr; 21(4):871-879. PubMed ID: 27309679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimizing the Start Time of Biologics in Polyarticular Juvenile Idiopathic Arthritis: A Comparative Effectiveness Study of Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans.
    Kimura Y; Schanberg LE; Tomlinson GA; Riordan ME; Dennos AC; Del Gaizo V; Murphy KL; Weiss PF; Natter MD; Feldman BM; Ringold S;
    Arthritis Rheumatol; 2021 Oct; 73(10):1898-1909. PubMed ID: 34105312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.